Stride

LRN · NYSE

$78.95−$2.04 (−2.52%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $80.99

LRN analyst rating

BuyConsensus of 4 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy2
Hold2
Underperform0
Sell0

12-month price target · 5 analysts

Average $121.94 (+54.5% upside)

Low: $93.93
Now: $78.95
High: $142.80

Upgrades and downgrades

The latest rating actions, newest first

LRN analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
BMO Capital	Oct 5, 2026	Maintains	Market Perform	$93.00 → $90.00	60%
Barrington Research	Apr 16, 2026	Maintains	Outperform	$125.00	63%
Canaccord Genuity	Jan 28, 2026	Maintains	Buy	$125.00	36%
Barrington Research	Jan 28, 2026	Maintains	Outperform	$125.00	63%
Barrington Research	Jan 21, 2026	Maintains	Outperform	$125.00	63%
Morgan Stanley	Dec 17, 2025	Maintains	Equal-Weight	$130.00 → $95.00	50%
BMO Capital	Nov 7, 2025	Maintains	Market Perform	$108.00 → $82.00	60%
Canaccord Genuity	Oct 29, 2025	Maintains	Buy	$175.00 → $125.00	36%
Barrington Research	Oct 29, 2025	Maintains	Outperform	$185.00 → $125.00	63%
BMO Capital	Oct 29, 2025	Downgrade	Outperform → Market Perform	$164.00 → $108.00	60%

The case for and against

Updated Jul 21, 2026

Bull case

Stride is demonstrating a strong track record of revenue growth, with a 7.5% increase in Q2, as well as increased enrollment and profitability. The successful resolution of platform issues and strong demand trends position the company well for a return to its expected growth pattern in FY27, and the recent stock repurchase program shows confidence in its future. The company also has a solid balance sheet, with cash and marketable securities totaling $625.7 million and a manageable long-term debt.

Bear case

Stride is currently trading at a high valuation of 1.2x FY/26 revenue and 4.9x revised adjusted EBITDA. Despite strong demand trends and better-than-expected second quarter results, the stock has already seen a significant increase (25%) in the premarket and may not have much room for further growth. As a result, the negative outlook is based on the high valuation and limited potential for further upside in the near term.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.